Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rallybio Corporation - Common Stock (NQ:RLYB)

10.71 -0.27 (-2.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rallybio Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 63 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Rallybio to Present at Upcoming Investor Conferences in November
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Announces Pricing of $50 Million Public Offering
From Rallybio
Via Business Wire
News headline image
Rallybio's Thrombocytopenia Candidate Shows Rapid, Complete Elimination Of Transfused Platelets ↗
 
Via Benzinga
News headline image
Rallybio Announces Proposed Public Offering
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Reports Third Quarter 2022 Financial Results
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Announces Positive Phase 1 Single Ascending Dose Results for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
From Rallybio Corporation
Via Business Wire
News headline image
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday ↗
   Losers 
Via Benzinga
News headline image
Peering Into Rallybio's Recent Short Interest ↗
Rallybio's (NASDAQ:RLYB) short percent of float has fallen 4.94% since its last report. The company recently reported that it has 638 thousand shares sold short, which is 2.5% of all regular shares... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. 
Via Benzinga
News headline image
FaZe Holdings, AXT And Some Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 700 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio to Present at the 2022 Wells Fargo Healthcare Conference
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Reports Second Quarter 2022 Financial Results
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors
From Rallybio Corporation
Via Business Wire
News headline image
69 Biggest Movers From Friday ↗
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
40 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. 
Via Benzinga
News headline image
Rallybio Announces Retirement of Jeffrey Fryer, CPA, Chief Financial Officer
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio to Present at Upcoming Investor Conferences in June
From Rallybio Corporation
Via Business Wire
News headline image
58 Biggest Movers From Yesterday ↗
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million. 
Via Benzinga
News headline image
Rallybio Reports First Quarter 2022 Financial Results
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
From Rallybio Corporation
Via Business Wire
News headline image
Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
From Rallybio Corporation
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 63 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was... 
Via Benzinga
News headline image
How Is The Market Feeling About Rallybio Corporation - Common Stock? ↗
Rallybio Corporation - Common Stock's (NASDAQ:RLYB) short percent of float has fallen 14.21% since its last report. The company recently reported that it has 446.60 thousand... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
Thursday saw 34 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: SecureWorks (NASDAQ:SCWX) was the largest company by market cap to... 
Via Benzinga
News headline image
Rallybio Reports Fourth Quarter and Full Year 2021 Financial Results
From Rallybio Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.